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Abstract
Background: To identify differences among men and women with acute coronary syndrome in
terms of in-hospital mortality, and to assess whether these differences are related to the use of
percutaneous cardiovascular procedures.
Methods: Observational study based on the Minimum Basic Data Set. This encompassed all
episodes of emergency hospital admissions (46,007 cases, including 16,391 women and 29,616 men)
with a main diagnosis of either myocardial infarction or unstable angina at 32 hospitals within the
Andalusian Public Health System over a four-year period (2000–2003). The relationship between
gender and mortality was examined for the population as a whole and for stratified groups
depending on the type of procedures used (diagnostic coronary catheterisation and/or
percutaneous transluminal coronary angioplasty). These combinations were then adjusted for age
group, main diagnosis and co-morbidityharlson score).
Results: During hospitalisation, mortality was 9.6% (4,401 cases out of 46,007), with 11.8% for
women and 8.3% for men. There were more deaths among older patients with acute myocardial
infarction and greater co-morbidity. Lower mortality was shown in patients undergoing diagnostic
catheterisation and/or PTCA. After adjusting for age, diagnosis and co-morbidity, mortality affected
women more than men in the overall population (OR 1.14, 95% CI: 1.06–1.22) and in the subgroup
of patients where no procedure was performed (OR 1.16, 95% CI: 1.07–1.24). Gender was not an
explanatory variable in the subgroups of patients who underwent some kind of procedure.
Conclusion: Gender has not been associated to in-hospital mortality in patients who undergo
some kind of percutaneous cardiovascular procedure. However, in the group of patients without
either diagnostic catheterisation or angioplasty, mortality was higher in women than in men.
Background
Many studies have been published on gender-related mor-
tality and outcomes in acute coronary syndrome [1-3].
Most of these studies have shown a higher unadjusted
mortality rate in women. For instance, Vaccarino [4], in
one of his longest studies on this topic, stated that unad-
justed prognosis was worse in women. However, differ-
ences in mortality decrease after adjustment for age, co-
morbidity, treatments and procedures.
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Several factors have been considered as possibly related to
a high mortality rate for women, namely, the onset of
acute coronary syndrome at a later age; an association
with a higher number of cardiovascular risk factors and
higher co-morbidity [5-8]; longer delay prior to receiving
healthcare [9,10] and lesser efforts both in terms of diag-
nosis and therapy received by women [11-13].
However, the effect of gender on mortality has not yet
been well defined and there are few data on how impor-
tant gender is as an independent determinant of disease
course in acute coronary syndrome patients. Also, little is
known on whether the gender link to mortality depends
on having undergone interventional procedures or not. It
has, however, been proven that women do not undergo
these procedures so frequently as their male counterparts
[14,15]; although it is also difficult to discern to what
extent this difference is accounted for by clinical and prog-
nostic issues.
The aim of this paper is to assess whether gender is a pre-
dictive variable for disease course in patients with acute
coronary syndrome, in terms of in-hospital mortality. The
paper is also intended to assess whether this association
depends on having undergone a percutaneous cardiovas-
cular procedure, for diagnostic and/or therapeutic pur-
poses.
Methods
Study scope and subjects
This study was conducted at the thirty-two public hospi-
tals within the Andalusian Public Health System between
1st January 2000 and 31st December 2003. This com-
prised all hospitalisation events recorded in the Minimum
Basic Data Set (MBDS: data base that records all dis-
charges, and that must be completed by all public hospi-
tals in Spain) that met the following selection criteria:
- Main diagnosis of acute myocardial infarction (AMI) or
unstable angina (UA). The corresponding codes for these
diagnoses are 410.01, 410.11, 410.21, 410.31, 410.41,
410.51, 410.61, 410.71, 410.81, 410.91, 411.1, 413.0,
413.1 and 413.9 in the ninth revision of the International
Classification of Diseases (ICD-9).
- Patients must be recorded as alive on arrival at hospital
and admitted urgently. This criterion is intended to avoid
any errors in those cases where the main diagnosis of AMI
or UA was coded for patients with a previous history of
ischaemic heart disease and who had been admitted for
some other non-emergency cause.
After this initial selection, discharges for transfer to
another acute-care hospital (5,187 records) were omitted
so as to avoid including the same hospital admission in
the study twice, given that these cases were generally
patients who were referred from hospitals without inter-
ventional procedure facilities to high level centres. All
records where gender was coded as indeterminate (113
records) were also ruled out, leaving a total of 46,007 hos-
pital admissions for acute coronary syndrome.
Variables examined
In-hospital mortality was the dependent variable. The
main independent variables were gender and perform-
ance of percutaneous procedures. All the procedure fields
included in the MBDS were searched to identify all percu-
taneous procedures performed. The performance of any or
none of the following procedures was identified among
the selected admissions for acute coronary syndrome:
diagnostic cardiac catheterisation (ICD-9 code: 37.21,
37.22, 37.23, 88.55, 88.56, 88.57) and percutaneous
transluminal coronary angioplasty (PTCA) (ICD-9 code:
36.01, 36.02, 36.05, 36.09, 36.06, 36.07, 36.09). A three-
category variable was then devised: performance of diag-
nostic catheterisation alone; performance of diagnostic
catheterisation and PTCA; no procedure performed.
Other explanatory variables that may act as confounding
or effect-modifying variables included:
- Age, in four age groups (<45 years, 45–64 years, 65–74
years, and >74 years).
- The main diagnosis recorded in the MBDS (UA or AMI).
- Co-morbidity studied by applying the Charlson score
(ChS) (Table 1), constructed on diagnostic fields included
in the Basic Minimum Data Set (MBDS). This score has
been validated and proven to predict mortality at 30 days
and one year post myocardial infarction [16,17]. This var-
iable was stratified in four categories for further analysis:
1: (ChS = 0, control), 2: (ChS = 1), 3: (ChS = 2) and 4:
(ChS ≥ 3). The ICHCALC 1.1 software was used to calcu-
late ChS – this programme was run on Microsoft Access©.
- A secondary diagnosis of diabetes mellitus in any hospi-
tal admission (coded ICD-9 code: 250.00 to 250.93).
Given its relevance, this co-morbidity was examined inde-
pendently.
Ethical issues
This is an observational study (the diagnostic and thera-
peutic procedures were all performed in the normal
course of care for patients with ACS and not in an experi-
mental context). The MBDS data were lent by the Andalu-
sian Regional Health Authority for this study. The data
were sent to the authors of this paper once the clinical
record number had been encrypted and the patients'
names and surnames deleted. As a result, the use of allBMC Health Services Research 2007, 7:110 http://www.biomedcentral.com/1472-6963/7/110
Page 3 of 7
(page number not for citation purposes)
data complies with Spanish regulations on data protec-
tion.
Statistical analysis
A descriptive analysis was conducted on in-hospital mor-
tality, according to the different independent variables.
The association between gender and mortality was ana-
lysed from a stratified standpoint according to the use
made of percutaneous procedures (three subgroups:
patients who had undergone no procedure at all, patients
who only underwent diagnostic catheterisation and
patients who underwent diagnostic catheterisation and a
PTCA). The magnitude of the association for each group
was evaluated by the odds ratio (OR), with a 95% confi-
dence interval and the χ2 test.
Multivariate logistic regression analysis by the forward
stepwise method was also performed with in-hospital
mortality as the dependent variable. One analysis was per-
formed for the population as a whole, examining gender,
use of procedures, age, main diagnosis and co-morbidity
as the independent variables. A further analysis was con-
ducted for each of the population subgroups defined
according to the use of percutaneous procedures, using
gender as the main independent variable and adjusting
for the remaining variables.
The SPSS 12.0 statistical package for Windows was used
for all analyses throughout the study.
Results
In-hospital mortality according to demographic and 
clinical features
During hospitalisation, mortality was 9.6% (4,401 cases
out of 46,007), with 11.8% for women and 8.3% for men.
(Table 2) Mortality was higher among older patients
(16% of patients over 74 years) and among patients diag-
nosed with AMI. Also, mortality rises with increased co-
morbidity – as measured by the Charlson score (Table 2).
Mortality was similar in both male and female patients in
the 45- to 64-year (3.8% for women, 4.0% for men, p =
0.63) and over 74-year (16% in women, 15.4% in men, p
= 0.37) age groups. There was a small, though statistically
significant, difference in the 65- to 74-year group,
(women 9.4%, men 8.4%, p = 0.047) and mortality was
clearly higher among women in the under 44 year-old
group (5% in women, 2% in men, p = 0.003).
The percentage of female diabetics who died was higher
than the percentage of men who died with the same diag-
nosis (12.3% and 10.2% respectively).
In-hospital mortality according to gender and use of 
procedures
No percutaneous procedure was performed in 80% of
hospital admissions (86% for women, and 77% for men).
In the remaining admissions, diagnostic catheterisation
was performed in 2,264 women (13.8%) and in 6,926
men (23.4%), as well as PTCA which was performed in
1,150 women (7.0%) and in 4,254 men (14.4%).
386 patients underwent CABG (64 women and 332 men).
Most of these patients had already undergone diagnostic
catheterisation. Given the small number of CABG patients
(0.8% of all patients in the study) and the low number of
deaths recorded (79 deaths, i.e. 1.7% of all deaths), it was
decided these patients should not be excluded from the
analysis. The sample size for this subgroup was too small
to allow for separate analysis.
Table 2: In-hospital mortality according to demographic and 
clinical features.
LIVE 
DISCHARGE
DEATH p
Total N % Total 
N
%
41,606 90.4 4,401 9.6
Gender <0.0001
Male 27,148 91.7 2,468 8.3
Female 14,458 88.2 1,933 11.8
Age <0.0001
<45 years 1,865 97.5 47 2.5
45–64 years 12,822 96.0 528 3.9
65–74 years 13,817 91.2 1,330 8.8
>74 years 13,102 84.0 2,996 16.0
Diagnosis <0.0001
UA 18,859 97.5 493 2.5
AMI 22,747 85.3 3,908 14.9
Co-morbidity <0.0001
ChS 0 22,217 92.2 1,867 7.8
ChS 1 13,991 89.7 1,613 10.3
ChS 3,586 87.2 526 12.8
ChS > 2 1,812 82.1 395 17.9
UA: Unstable angina. AMI: acute myocardial infarction. ChS: Charlson 
score.
Table 1: Weighting of Concurrent Diseases Included in the 
Charlson Score*
Acute myocardial 
infarction
1 Diabetes, chronic complications 2
Congestive heart failure 1 Hemiplegia or paraplegia 2
Peripheral cardiovascular 
disease
1R e n a l  d i s e a s e 2
Dementia 1 Malignant tumours 2
Chronic pulmonary 
disease
1 Moderate/severe hepatic disease 3
Peptic ulcer 1 Solid metastatic tumour 6
Mild hepatic disease 1 AIDS 6
Mild-moderate diabetes 1
*AIDS indicates acquired immune deficiency syndrome.BMC Health Services Research 2007, 7:110 http://www.biomedcentral.com/1472-6963/7/110
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In the stratification analysis according to use of proce-
dures (without adjustment for other variables), greater
mortality rates were seen among women than among
men, both in the group without either diagnostic catheter-
isation or PTCA and in the group undergoing both proce-
dures. No statistically significant differences were seen in
mortality rates between men and women among patients
where only diagnostic catheterisation had been per-
formed (Table 3).
In the multivariate analysis for the population as a whole
(Table 4), in-hospital mortality was higher in women, in
the older age group of patients, in patients with a diagno-
sis of AMI and higher co-morbidity. Lower mortality was
seen in patients who underwent diagnostic catheterisation
(performed alone or in association with PTCA) compared
with patients who underwent no procedure at all. The var-
iable diabetes did not enter in this multivariate model.
However, this excess mortality seen in women when look-
ing at the population as a whole is not present in all the
subgroups defined according to the use made of proce-
dures (no procedure, diagnostic catheterisation, diagnos-
tic catheterisation and PTCA). As a result, in the
multivariate analysis for each of these subgroups individ-
ually, gender has no impact in the two groups who under-
went some kind of procedure, either for diagnostic or
therapeutic purposes (Table 5). After adjusting for age,
diagnosis and co-morbidity, the higher mortality rate for
women was only seen in the subpopulation with no per-
cutaneous procedure. In the three regression models, the
remaining variables (age, diagnosis and co-morbidity)
yield the same results as for the model including the pop-
ulation as a whole (Table 5).
Discussion and conclusion
No differences in terms of in-hospital mortality were seen
in this study between women and men admitted urgently
to hospital for UA or AMI who underwent diagnostic cath-
eterisation and/or PTCA. However, higher mortality was
seen among women in the group of patients who under-
went no procedure at all.
A well-defined population was selected for this study,
namely patients with a confirmed diagnosis leading to
emergency admission, so as to ensure relatively homoge-
neous groups of populations of both men and women in
terms of indication for interventional procedures. With a
confirmed diagnosis in all cases as the cause for hospital
admission, the hypothesis that the diagnosis of ACS is
more difficult in women can be ruled out as the main
underlying explanation for the differences found in the
use of these procedures.
The main limitations in this study stem from the use of a
secondary data source (MBDS). This does not allow for
more in-depth analysis of the possible causes of the gen-
der-derived differences, and explanations must be found
based only on the variables included in the database (gen-
der, age, procedures, co-morbidity and main diagnosis).
As a result, the role of previous heart disease in these
patients and other clinical variables, such as number of
vessels involved, ejection fraction, shock upon admission,
and treatment delivered, cannot be explored. Diagnosis of
AMI has changed since the introduction of troponin in
2000, which may have had an impact on the results.
Nonetheless, it might not affect the comparison between
men and women. No distinction can be made between
co-morbidities present at the time of admission and com-
plications occurring during hospital stay or cause of
Table 4: Multivariate logistic regression models for the 
population as a whole: Variables associated with in-hospital 
mortality.
Variables (*) OR 95% CI
Gender
Female 1.14 1.06 1.22
Age
65–74 years 0.61 0.56 0.65
45–64 years 0.28 0.25 0.31
< 45 years 0.16 0.12 0.21
Diagnosis
AMI 7.27 6.60 8.01
Co morbidity 
(Charlson Score)
ChS 1 1.17 1.09 1.26
ChS 2 0.45 0.13 0.62
ChS > 2 2.30 2.03 2.62
Performance of 
procedures
Diagnostic Catheterisation 0.65 0.56 0.76
Diagnostic Catheterisation and PTCA 0.42 0.37 0.49
* The reference categories were: male gender, age > 74 years, 
diagnosis of unstable angina, Charlson = 0, no procedure performed.
AMI: Acute myocardial infarction. ChS: Charlson Score. PTCA: 
percutaneous transluminal coronary angioplasty
Table 3: In-hospital mortality by gender: Stratified analysis 
according to performance of percutaneous procedures.
LIVE 
DISCHARGE
DEATH
Total N % Total N % p
41,606 90.4 4,401 9.6
No procedure <0.0001
Male 20,531 90.5 2,159 9.5
Female 12,320 87.2 1,807 12.8
Only diagnostic 
catheterisation
0.377
Male 2,521 94.3 151 5.7
Female 1,059 95.1 55 4.9
Diagnostic 
catheterisation and 
PTCA
<0.0001
Male 4,096 96.3 158 3.7
Female 1,079 93.8 71 6.2
PTCA: percutaneous transluminal coronary angioplastyBMC Health Services Research 2007, 7:110 http://www.biomedcentral.com/1472-6963/7/110
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death. Under-reporting of procedures in the MBDS cannot
be ruled out. However, we do not think that such under-
reporting will affect the comparison between men and
women, i.e. the main aim of this paper.
Adjustment of in-hospital mortality has been widely used
to assess the quality of healthcare provided for heart-dis-
ease patients [18]. However, there is some controversy
over the differences in mortality rates in ACS among men
and women, according to whether these patients undergo
invasive cardiovascular procedures or not. Some studies
have shown that women who undergo an invasive proce-
dure for either diagnostic or therapeutic purposes die
more often than men, especially if they are older and diag-
nosed with AMI. This has led to a less frequent indication
for these procedures among women [4,12,13,15,19].
Other authors however, such as Vacek and Mehilli
[20,21], detect no such differences.
The in-hospital mortality rates found in this study are sim-
ilar to those reported in other studies also using the MBDS
[22]. The results for the population as a whole show that
gender is related to mortality; however, as other publica-
tions report [23], there is no difference in mortality
between men and women when the analysis is limited to
the group of patients who undergo some kind of percuta-
neous procedure.
As seen by other authors, age, a diagnosis of AMI and the
patient's clinical status when undergoing interventional
procedures show a stronger link with mortality than gen-
der [21-27]. Several authors have suggested that older age,
worse clinical status on admission, greater frequency of
associated diabetes, together with a faster, more lethal
course of AMI, may account for a higher in-hospital mor-
tality rate among women [6,23,28-32]. However, a delay
in diagnosis due to inadequate symptom identification,
and subsequent delay in both drug and interventional
therapy, may also have an impact [9,13,26]. Delay in
delivering therapeutic measures in women is one of the
determining factors in their disease course and is also a
factor that could easily be changed [33]. All these factors,
together with a lesser effort in diagnosis and therapy (i.e.
admission to intensive care units, performance of diag-
nostic catheterisation and PTCA, etc.) may jointly account
for the differences seen in mortality rates between men
and women.
In this respect, this study revealed that percutaneous cor-
onary procedures are associated with lower mortality,
both when diagnostic catheterisation is performed alone
(the results of this test may lead to positive medical deci-
sions for the patient) and when followed by PTCA. The
high percentage of patients undergoing neither of these
procedures is striking, both among men and women,
although this is even more remarkable among women. At
least, this was the case in the context of this study (acute
hospital admissions). Other variables, apart from gender,
that were associated with diagnostic catheterisation and
PTCA were age, diagnosis, and the Charlson score (wider
use of this procedures in patients under 65, with a diagno-
sis of myocardial infarction and with higher co-morbid-
ity); as has been reported elsewhere [12]. So, the observed
association between cardiac catheterisation and reduced
mortality may be partly related to lower baseline illness
severity among patients referred for catheterisation.
Table 5: Multivariate logistic regression models for each 
population subgroup, defined according to use of percutaneous 
cardiovascular procedures: Variables associated with in-hospital 
mortality.
Variables (*) OR 95% CI
No procedure (N = 36,817)
Gender
Female 1.16 1.07 1.24
Age
65–74 years 1.01 0.69 1.47
45–64 years 0.28 0.25 0.31
<45 years 0.17 0.12 0.24
Diagnosis
AMI 7.53 6.80 8.33
Charlson
ChS 1 1.17 1.08 1.27
ChS 2 1.46 1.30 1.64
ChS > 2 2.31 2.02 2.64
Diagnostic Catheterisation (N = 3,786)
Age
65–74 years 1.01 0.69 1.47
45–64 years 0.43 0.28 0.66
<45 years 0.08 0.02 0.35
Diagnosis
AMI 4.17 2.89 6.00
Charlson
ChS 1 1.22 0.89 1.68
ChS 2 1.63 1.00 2.65
ChS > 2 2.05 1.08 3.86
Diagnostic Catheterisation and PTCA (N = 5,404)
Age
65–74 years 0.64 0.45 0.92
45–64 years 0.27 0.19 0.40
<45 years 0.18 0.09 0.38
Diagnosis
AMI 7.63 4.02 14.48
Charlson
ChS 1 1.13 0.84 1.52
ChS 2 1.02 0.56 1.86
ChS > 2 2.73 1.42 5.25
* The reference categories were: male gender, age > 74 years, 
diagnosis of unstable angina, Charlson = 0.
AMI: Acute myocardial infarction. ChS: Charlson Score. PTCA: 
percutaneous transluminal coronary angioplastyBMC Health Services Research 2007, 7:110 http://www.biomedcentral.com/1472-6963/7/110
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However, the fact that a higher mortality rate for women
(after adjusting for age, co-morbidity and diagnosis) is
seen only in the subgroup of patients where no interven-
tion at all was performed, suggests that there is still room
for improvement in terms of providing percutaneous pro-
cedures for women.
The risk of death is determined more by variables such as
age, diagnosis and the patient's clinical status than by the
gender variable. However, gender may indeed be influenc-
ing current decision-making for more or fewer interven-
tional measures, given that women comprise the group of
patients where fewer diagnostic and therapeutic efforts
have been made to date. This lesser effort may partly
account for the higher mortality rates seen among female
patients.
The gaps in our understanding of acute coronary syn-
drome and its behaviour in men and women must now be
bridged. A different interventional attitude towards the
diagnosis and treatment of female acute coronary syn-
drome patients may well contribute to enhanced disease
control and improved mortality for this group of patients.
Only by having valid studies will we be able to set opti-
mum protocols of care and enhance survival outcomes.
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